Dicerna Pharmaceuticals
Archemix and Dicerna to Collaborate on Conjugated Aptamer-Dicer Substrate RNAi Therapeutics
Published in Pharma Investments, Ventures and Law Weekly, August 9th, 2009
Archemix Corp., a biotechnology company focused on discovering, developing and commercializing aptamer therapeutics, and Dicerna Pharmaceuticals, Inc., a second generation RNA interference (RNAi) company developing novel therapeutics utilizing its proprietary Dicer Substrate Technology™ and dicer substrate RNA (DsiRNA) molecules, announced that the two companies have entered into an agreement to collaborate on aptamer-DsiRNA therapeutics that leverage both the intracellular delivery capabilities of Archemix's aptamers, and the potent gene silencing of Dicerna's DsiRNA molecules. Both companies are making an investment of resources to develop the aptamer-DsiRNA therapeutics, and will...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Investments, Ventures and Law Weekly
More Articles from Pharma Investments, Ventures and Law Weekly
- A.P. Pharma, Inc.
A.P. Pharma Receives Nasdaq Notice of Non-Compliance; Company to Request Hearing - AAUW
AAUW Supports Confirmation of Judge Sotomayor - Addus HomeCare Corporation
Addus HomeCare Corporation Files Registration Statement - American Academy of Actuaries
Actuaries: Federal Long-Term Care Legislation Falls Short on Coverage Goals - American Association of Homes and Services for the Aging
Energy and Commerce Committee Advances Long-Term Services and Supports in Health Care Reform - American Civil Liberties Union
DHS Continues State and Local Immigration Enforcement Program Without Meaningful Changes - More from this issue of Pharma Investments, Ventures and Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
